Introduction {#s01}
============

Germinal centers (GCs) are transient structures that form around the follicular dendritic cell (FDC) networks located within secondary lymphoid organs 4--7 d after challenge with foreign T cell--dependent antigens ([@bib13]; [@bib34]). Antigen-specific B cells recruited into GCs undergo somatic hypermutation (SHM) of the Ig variable region genes that encode the binding specificity of the clonal B cell receptor (BCR). Clones acquiring increased affinity for antigen via SHM are preferentially retained within the GC in a process known as positive selection ([@bib5]; [@bib17]). In addition, differentiation of GC B cells into antibody-secreting plasma cells (PCs) is restricted to those with high affinity for antigen ([@bib32]; [@bib28]). Together, these processes ensure that the GC output is made up of the most effective antibodies possible, thus providing the basis for long-term serological immunity after infection and vaccination ([@bib29]).

GC B cells consist of spatially and phenotypically distinct light-zone (LZ) and dark-zone (DZ) populations with CXCR4^lo^ CD86^hi^ and CXCR4^hi^ CD86^lo^ cell surface phenotypes, respectively ([@bib35]; [@bib3]). The signals that sustain GC B cell responses are localized within the LZ in the form of (a) intact antigen displayed on the surface of FDCs and (b) T follicular helper cells (Tfh cells) that bind processed antigenic peptides presented with class II MHC molecules on the B cell surface ([@bib13]; [@bib34]). LZ B cells transit to the DZ where they undergo cell division and SHM before returning to the LZ. Preferential activation of high-affinity GC B cells in the LZ is widely accepted to mediate positive selection. However, PCs appear to exit from the DZ of the GC ([@bib23]), and it remains unclear where and how PC differentiation is initiated within GCs. Conclusions drawn from mathematical modeling ([@bib22]), two-photon microscopy ([@bib1]), and loading of GC B cells with extrinsic peptide ([@bib35]) have led to the suggestion that high-affinity GC B cells receive enhanced Tfh cell help. However, definitive identification of the stimulus that determines selective differentiation of high-affinity GC B cells into PCs awaits detailed characterization of the differentiation process within GCs and the impact of specific abrogation of signals delivered by direct engagement of intact antigen on FDCs versus those provided by Tfh cell help.

Results and discussion {#s02}
======================

To facilitate such a study, we developed a high-resolution in vivo model in which the phenotype and fate of high- and low-affinity GC B cells are clearly identifiable. CD45.1-marked B cells from SW~HEL~ mice, expressing the anti--hen egg lysozyme (HEL) specificity of the HyHEL10 mAb ([@bib27]), were transferred into wild-type (CD45.2^+^) recipient mice and challenged with the low-affinity (*Κ~a~* ∼10^7^ M^-1^) HEL^3X^ protein coupled to sheep RBCs (SRBCs; HEL^3X^-SRBCs; [Fig. 1 A](#fig1){ref-type="fig"}; [@bib26]; [@bib10]). Donor SW~HEL~ B cells form GCs on days 4--5 of the response ([@bib9]) and undergo affinity-based selection to HEL^3X^. By day 9, ∼50% of IgG1-switched LZ and DZ B cells possess high affinity for HEL^3X^ (i.e., LZhi/DZhi GC B cells) as defined by flow cytometric staining with limiting HEL^3X^ ([Fig. 1 B](#fig1){ref-type="fig"}). High-affinity SW~HEL~ GC B cells carry the Y53D Ig heavy chain substitution (Fig. S1; [@bib28]), which conveys an ∼100-fold increase in HEL^3X^-binding affinity ([@bib10]).

![**Identification of high- and low-affinity LZ and DZ SW~HEL~ GC B cells and their affinity-dependent gene expression signatures.** (A) General experimental strategy. (B) Flow cytometric gating used to sort and characterize donor-derived SW~HEL~ GC B cells. IgG1^+^ GC B cells are resolved into high- and low-affinity DZ and LZ populations (DZhi, DZlo, LZhi, and LZlo). (C) Heat map showing genes differentially expressed between DZ and LZ GC B cells regardless of BCR antigen affinity. Genes encoding markers used to define the DZ and LZ subsets (*Cd86* and *Cxcr4*) are indicated in red. The fold-change cutoff was set to ≥1.5984 (= fold-change up-regulation of *Cxcr4* in DZ vs. LZ) with P ≤ 0.0005. (D and E) Heat maps showing genes differentially expressed according to BCR antigen affinity within either the DZ (D) or LZ (E). (F) GSEA of relative gene expression in total LZ versus total DZ GC B cells (left) or LZlo versus LZhi GC B cells (middle) against the gene set identified as up-regulated after CD40L stimulation of the human GC B cell line Ramos ([@bib4]) and LZlo versus LZhi GC B cells against genes up-regulated by antigen (HEL) stimulation of B cells expressing an IgM BCR with an IgG1 cytoplasmic tail ([@bib16]). FDRq, false discovery rate. Gene expression data represent four independent experiments of 25 mice per experiment.](JEM_20161533_Fig1){#fig1}

Using gene expression microarray analysis, we confirmed that HEL^3X^-specific LZ and DZ GC B cells differentially express a core set of 62 genes regardless of antigen affinity ([Fig. 1 C](#fig1){ref-type="fig"}) and that this gene expression signature corresponds closely to that previously identified in anti-NP GC responses (Fig. S2 A; [@bib35]). However, upon further analysis, we found additional sets of genes displaying affinity-dependent expression, particularly within the LZ compartment ([Fig. 1, D and E](#fig1){ref-type="fig"}). Gene set enrichment analysis (GSEA) confirmed previous findings ([@bib35]) that LZ rather than DZ GC B cells possess a gene expression signature that most closely mirrors that of a GC B cell line (Ramos) after CD40 ligand (CD40L) stimulation ([Fig. 1 F](#fig1){ref-type="fig"}, left; [@bib4]). Interestingly, this signature was stronger in LZlo compared with LZhi cells ([Fig. 1 F](#fig1){ref-type="fig"}, middle), suggesting that LZhi cells may receive signals other than those derived from Tfh cells. A gene expression signature derived from antigen-stimulated B cells expressing a BCR with an IgG1 cytoplasmic tail ([@bib16]) showed a slightly stronger similarity to LZhi versus LZlo GC B cells ([Fig. 1 F](#fig1){ref-type="fig"}, right). Overall, however, it was not possible to make strong conclusions about the signals delivered to LZhi versus LZlo GC B cells on the basis of gene expression profiling alone.

We next set out to (a) characterize the process of PC differentiation within the GC and (b) identify the impacts on this process of specific abrogation of antigen engagement versus Tfh cell help. We found that DZ B cells displayed a more prominent PC gene signature ([@bib24]) than LZ B cells (Fig. S2 B), with DZhi cells in particular expressing canonical PC genes (e.g., *Prdm1/Blimp1*, *Sdc1*, *Cd93*, *Igj*, and *Xbp1*; [Fig. 2 A](#fig2){ref-type="fig"}) and exhibiting a strong PC gene expression signature relative to DZlo cells ([Fig. 2 B](#fig2){ref-type="fig"}). Nevertheless, a PC gene signature was also evident in LZhi versus LZlo cells ([Fig. 2 C](#fig2){ref-type="fig"}), and analysis of responses from SW~HEL~ B cells carrying the *Blimp1^gfp^* reporter gene ([@bib19]) confirmed that PC-lineage cells (*Blimp1*-GFP^+^) are present within both the DZhi and LZhi compartments ([Fig. 2 D](#fig2){ref-type="fig"} and Fig. S2 C). Based on established PC biology ([@bib19]), we hypothesized that the GC cells with lowest *Blimp1*-GFP reporter and highest BCR (IgG1) expression were those most recently committed to PC differentiation. This was supported by the fact that *Blimp1*-GFP^lo^ IgG1^hi^ cells expressed higher levels of B220 and CD45 than *Blimp1*-GFP^hi^ IgG1^lo^ PC-lineage cells ([Fig. 2 E](#fig2){ref-type="fig"}; [@bib18]; [@bib21]). Significantly, we found that *Blimp1*-GFP^+^ cells in the LZ almost exclusively possess an early PC-lineage phenotype (*Blimp1*-GFP^lo^ IgG1^hi^; [Fig. 2 F](#fig2){ref-type="fig"}). Therefore, our data indicated that PC differentiation is initiated by signals delivered to LZhi GC B cells, with subsequent transition to a late PC phenotype (*Blimp1*-GFP^hi^ IgG1^lo^) occurring after migration into the DZ. This is consistent with a previous report that presumptive PC-lineage cells expressing high levels of the *Blimp1-*inducing transcription factor IRF4 ([@bib30]) are present in the LZ of human tonsillar GC ([@bib12]) and that the LZhi compartment defined in the present study displays the highest levels of *Irf4* mRNA expression in the GC ([Fig. 2 A](#fig2){ref-type="fig"}).

![**Identification of early and late PC-lineage cells in the GC and enrichment of early PCs in the LZ.** (A) Heat map of selected genes known to be up-regulated (top eight) or down-regulated (bottom three) in PCs, indicating a strong PC gene expression signature in the DZhi compartment. (B and C) GSEA of differential gene expression according to antigen affinity within the DZ (B) and LZ (C) compartments, against gene sets either up-regulated (left) or down-regulated (right) in PCs ([@bib24]). FDRq, false discovery rate. (D) Proportion of cells within each of the four GC subcompartments detected as *Blimp1*-GFP^+^ on day 9 of the SW~HEL~.*Blimp1^gfp/+^* response to HEL^3X^-SRBCs. (E, top) Day 9 GC B cells derived from SW~HEL~.*Blimp1^+/+^* and SW~HEL~.*Blimp1^gfp/+^* donor B cells resolving *Blimp1*-GFP^lo^, IgG1^hi^, and *Blimp1*-GFP^hi^ IgG1^lo^ subpopulations. (Bottom) Histogram overlays showing higher B220 and CD45 staining on the *Blimp1*-GFP^lo^ IgG1^hi^ population. (F) Flow cytometric analysis of the LZ and DZ phenotypes of *Blimp1*-GFP^+^ IgG1^+^ GC B cells. Data from are representative of five independent experiments of five mice per group. Flow cytometry plots are concatenated data from five recipient mice. P-values were calculated using a paired Student's *t* test. \*, 0.01 ≤ P \< 0.05; \*\*, 0.001 ≤ P \< 0.01.](JEM_20161533_Fig2){#fig2}

To interrogate the specific roles of Tfh cell help versus antigen engagement in PC differentiation, we again challenged transferred SW~HEL~.*Blimp1^gfp/+^* B cells with HEL^3X^-SRBCs. On day 6 of the response (after GC formation), recipients were injected with mAbs that block (anti-CD40L) or deplete (anti-CD4) Tfh cell help, and the effect on GC responses was assessed 3 d later (day 9; [Fig. 3, A and B](#fig3){ref-type="fig"}). To block BCR access to FDC-bound antigen (HEL^3X^), recipients were injected with HyHEL10\*, a soluble IgG1 homologue of the SW~HEL~ BCR carrying three heavy chain mutations (S31R, Y53D, and Y58F) that confer very high affinity (*Κ~a~* \>10^−10^ M^-1^; [@bib10]) for HEL^3X^. To exclude possible FcγR-mediated effects in this case, control recipients were injected with HyHEL9, an IgG1 mAb that binds HEL and HEL^3X^ with very high affinity (*Κ~a~* \>10^−10^ M^−1^) but does not compete with HyHEL10 ([Fig. 3 A](#fig3){ref-type="fig"}; [@bib33]).

![**Blocking antigen access, but not Tfh cell help, prevents initiation of PC differentiation in the GC.** (A) Schematic of antigen engagement and reception of cognate CD4^+^ Tfh cell help by SW~HEL~ B cells in unmanipulated GCs (top), plus the mAb-based approaches used to specifically block Tfh cell help (bottom left) or block engagement of intact antigen by the SW~HEL~ BCR (bottom right). Both HyHEL10\* and HyHEL9 bind to HEL^3X^, but only HyHEL10\* blocks access to the antigen by the SW~HEL~ BCR. (B) Experimental design for mAb-blocking experiments. SW~HEL~.*Blimp1^gfp/+^* B cells were permitted to form GCs in response to HEL^3X^-SRBCs and recipients and then given a single injection of mAbs 2 or 3 d before spleen harvest and analysis on day 9. (C and D) Impact of 3 d of mAb treatment on IgG1^+^ PC-lineage cells in GCs derived from SW~HEL~.*Blimp1^gfp/+^* donor B cells. Representative flow cytometry profiles are shown (C), as well as enumeration of early (*Blimp1*-GFP^lo^ IgG1^hi^) and late (*Blimp1*-GFP^hi^ IgG1^lo^) PC-lineage populations in individual recipients (D). (E and F) Impact of 2 d of HyHEL10\* treatment analyzed as for C and D. Data from each mAb treatment are representative of two to four independent experiments of five mice per group. Flow cytometry plots are concatenated data from five recipient mice. P-values were calculated using an unpaired Student's *t* test. \*\*, 0.001 ≤ P \< 0.01.](JEM_20161533_Fig3){#fig3}

Treatment with either HyHEL10\* anti-CD4 or CD40L for 3 d led to similar (40--60%) reductions in the overall size of the GC response, with the DZ compartment most impacted in each case (Fig. S3 A). However, only antigen blockade with HyHEL10\* abolished PC differentiation, removing both early (*Blimp1*-GFP^lo^ IgG1^hi^) and late (*Blimp1*-GFP^hi^ IgG1^lo^) PC-lineage cells ([Fig. 3, C and D](#fig3){ref-type="fig"}). The fact that both anti--Tfh cell treatments reduced GC size without preventing PC differentiation indicated that the abrogation of PC differentiation by HyHEL10\* cannot be attributed to impaired antigen presentation and reduced Tfh cell help. Instead, HyHEL10\* must act by preventing delivery of signals normally imparted to LZhi GC B cells directly upon antigen engagement. The specific impact of antigen blockade on the induction of PC differentiation was also evident after 2 d of HyHEL10\* treatment (from days 7 to 9), which selectively depleted early PC-lineage cells ([Fig. 3, E and F](#fig3){ref-type="fig"}) including all LZ phenotype cells (not depicted). Analysis of the IgG1^−^ (predominantly IgG2b^+^) PC-lineage cells in the GC showed similar results (not depicted), indicating that the triggering of the PC differentiation pathway by antigen engagement is a mechanism that is likely to apply generally to IgG-switched GC responses.

Although the overall numbers of PC-lineage cells were largely unchanged by abrogation of Tfh cell help, anti-CD4 (but not anti-CD40L) treatment had a pronounced qualitative impact. Thus, in direct contrast to antigen blockade, Tfh cell depletion resulted in the relative enrichment of early PC-lineage cells ([Fig. 3, C and D](#fig3){ref-type="fig"}). Accordingly, anti-CD4 (but not anti-CD40L) treatment also increased the fraction of PC-lineage cells that exhibited an LZ phenotype ([Fig. 4, A and B](#fig4){ref-type="fig"}). To determine whether this shift in the phenotype of PC-lineage cells was associated with physical retention in the LZ, immunofluorescence histology was undertaken. PC-lineage cells were identifiable by their strong cytoplasmic expression of IgG1 and localized primarily within the DZ of control GCs before appearing to exit through the base of the DZ ([Fig. 4 C](#fig4){ref-type="fig"} and Fig. S3 B; [@bib23]). As has been described previously ([@bib2]; [@bib23]), many PC-lineage cells (30--40% by our enumeration) are found in small clusters in or just outside the GC, suggesting that ongoing cell division may occur during early PC differentiation. LZ PC-lineage cells were in natural proximity to LZ-resident FDCs ([Fig. 4 C](#fig4){ref-type="fig"}), raising the possibility that they may access antigen via the immune complexes displayed on the FDC surface. Strikingly, LZ PC-lineage cells were greatly enriched in GCs from mice treated with anti-CD4 ([Fig. 4 C](#fig4){ref-type="fig"}). LZ retention of PC-lineage cells was not seen upon treatment with anti-CD40L (Fig. S3 C), confirming that Tfh cell--derived signals other than CD40L are required to drive the LZ egress and phenotypic maturation of LZhi GC B cells that have been previously licensed to initiate PC differentiation upon direct engagement of antigen.

![**PC-lineage cells are enriched in the LZ after depletion of CD4^+^ Tfh cells and colocalize with FDCs.** (A and B) GC responses were established from SW~HEL~.*Blimp1^gfp/+^* B cells and subjected to 3-d treatment with either anti-CD40L (A) or anti-CD4 (B) as outlined in [Fig. 3](#fig3){ref-type="fig"}. (Left) Representative flow cytometry profiles indicate the impact of mAb treatments on the LZ and DZ phenotypes of IgG1^+^ PC-lineage cells (*Blimp1*-GFP^+^). (Right) The proportions of IgG1^+^ PC-lineage cells that fell within the DZhi, DZlo, LZhi, and LZlo compartments in individual recipients were also enumerated. (C) Immunofluorescence histology of spleens from recipient mice 9 d after transfer of SW~HEL~ B cells plus HEL^3X^-SRBCs and 3 d after injection of isotype control or anti-CD4 mAb. The B cell follicle (Fo) is marked by IgD (white), the LZ by CD35 (FDCs; red), and the DZ by CXCR4 (blue). The unstained T cell zone (TZ) is also indicated. IgG1^+^ PC-lineage cells are identifiable by bright (cytoplasmic) staining (green). Frequencies of IgG1^+^ PC-lineage cells identified within the LZ (containing CD35^+^ FDCs) by immunofluorescence analysis were 7% (5/66) in isotype-treated and 69% (76/110) in anti-CD4--treated mice (enumerated over 17 and 16 individual GCs, respectively). Bars, 50 µm. Data are representative of two to four independent experiments of five mice per group (A and B) or are representative of four independent experiments of five mice per group (C). P-values were calculated using an unpaired Student's *t* test. \*\*\*, P \< 0.001.](JEM_20161533_Fig4){#fig4}

The exquisite selectivity of PC differentiation for high-affinity GC cells ([@bib28]) means that its underlying mechanism must be tightly linked to antigen affinity. This condition is clearly satisfied by our finding that signals delivered upon antigen engagement are responsible for the initiation of PC differentiation among LZhi GC B cells. Although it remains unclear whether LZhi cells present more peptide antigen than LZlo cells, our gene microarray data raise the question of whether LZhi cells do preferentially receive Tfh cell help ([@bib35]; [@bib31]). A determining role for Tfh cells in driving PC differentiation had been proposed based on the finding that GC B cells undergo DZ migration and PC differentiation en masse when they are loaded with exogenous peptide recognized by resident Tfh cells ([@bib35]). Our observations do indeed support the conclusion that Tfh cell help promotes DZ migration of committed PC-lineage cells, interestingly via signals other than CD40L. However, because depletion of Tfh cell help did not impact upon the initiation of PC differentiation in our study, we argue that boosting of Tfh cell help with exogenous peptide provides a supraphysiological stimulus to GC B cells that can drive PC differentiation regardless of BCR affinity, much like B cells stimulated with excess CD40L and cytokines in vitro ([@bib15]). Thus, although Tfh cell help is clearly required to progress PC differentiation and migration within the GC, it is signals delivered directly upon BCR engagement of intact antigen, most likely from the surface of FDCs, that initiate this process under physiological conditions. Therefore, our findings recall the bipartite two-signal paradigm of immune activation originally proposed by [@bib6] to prevent activation of self-reactive lymphocytes. Applied to the dynamic BCR repertoire of somatically mutating GC B cells, the need for a discriminating signal 1 (engagement of high-affinity antigen) to be supplemented with signal 2 (cognate Tfh cell help) provides a mechanism not only for selective production of high-affinity antiforeign antibodies, but also of preventing production of high-affinity autoantibodies that can arise because of chance SHM events ([@bib7]).

The specific nature of the stimulus that initiates PC differentiation after engagement of FDC-bound antigen remains unclear. Although there are conflicting data regarding the ability of the BCRs of GC B cells to deliver intracellular signals ([@bib20]; [@bib25]), many ligands associated with FDCs can engage GC BCRs and may act with or without BCR signaling to initiate PC differentiation. These include complement fragments (e.g., C3d), adhesion molecules (ICAM-1/VCAM-1), IL-6, B cell--activating factor, and C4BP ([@bib11]; [@bib14]). An intriguing question is whether signals delivered directly upon antigen engagement as opposed to enhanced antigen presentation may also be the primary driver of positive selection in the GC. The iterative nature of positive selection as opposed to the linear progression of PC differentiation makes this a more difficult issue to resolve. However, the clear implication of our findings is that either (a) antigen engagement acts as the master regulator of both positive selection and PC differentiation within the GC or (b) these two key processes rely on distinct selective mechanisms.

Materials and methods {#s03}
=====================

Mice, adoptive transfers, and in vivo antibody treatments {#s04}
---------------------------------------------------------

SW~HEL~ mice ([@bib27]) were maintained on a congenic CD45.1 (*Ptprc^a/a^*) C57BL/6 background. To facilitate tracking of PC differentiation, SW~HEL~ mice were interbred with *Blimp1^gfp/+^* mice ([@bib19]). For adoptive transfers, 6--10-wk-old wild-type C57BL/6 recipient mice (Australian BioResources) received 3 × 10^4^ HEL-binding SW~HEL~ B cells intravenously in combination with 2 × 10^8^ HEL^3X^-conjugated SRBCs ([@bib26]). To block interaction of GC B cells with Tfh cells or native antigen, mice were treated with 200 µg anti-CD4 (GK1.5; rat IgG2b; Bio X Cell), 200 µg anti-CD40L (MR-1; hamster IgG; University of California, San Francisco \[UCSF\] Monoclonal Antibody Core), or 50 µg HyHEL10\* (HyHEL10 carrying Y53D/S31R/Y58 mutations; mouse IgG1; produced in house) at the indicated time points. Control groups received equal amounts of the respective isotype control antibodies. Animal studies were approved and conducted in compliance within the guidelines set down by the Garvan/St. Vincent's Animal Ethics Committee.

HEL proteins and HyHEL antibodies {#s05}
---------------------------------

Recombinant HEL^3X^ was produced in yeast (*Pichia pastoris*) and purified from culture supernatants as previously described ([@bib26]). HyHEL10\* IgG1 mAb was expressed in HEK293 cells and purified as previously described ([@bib8]), and HyHEL9 was supplied by the UCSF Monoclonal Antibody Core.

Flow cytometry {#s06}
--------------

Recipient splenocytes were prepared and stained for cell surface HEL^3X^ and IgG1 as previously described ([@bib10]) and subsequently incubated with the additional directly conjugated antibodies and streptavidin reagents. Donor-derived (SW~HEL~) GC B cells were identified as CD45.1^+^, CD45.2^−^, B220^+^, and CD38^lo^ ([Fig. 1 B](#fig1){ref-type="fig"}). Flow cytometric data were acquired on an LSRII SORP flow cytometer (BD), and data were analyzed by FlowJo software (Tree Star). For sort purification of single (SHM analysis) or bulk GC B cells, samples were isolated using a FACSAria III flow cytometer (BD).

SHM analysis {#s07}
------------

Single LZhi, LZlo, DZhi, and DZlo IgG1^+^ SW~HEL~ GC B cells (see gates in [Fig. 1 B](#fig1){ref-type="fig"}) were sorted into 96-well plates, and the variable region exon of the SW~HEL~ immunoglobulin heavy chain variable region exon (HyHEL10) was PCR amplified and sequenced as previously described ([@bib26]).

mRNA microarray and computational data analysis {#s08}
-----------------------------------------------

SW~HEL~ B cell subpopulations (minimum 16,800 cells) were gated as outlined in [Fig. 1 B](#fig1){ref-type="fig"} and sorted directly into TRIzol (Invitrogen), and RNA extraction was performed according to the manufacturer's instructions. To improve recovery, RNA was precipitated with GlycoBlue (Thermo Fisher Scientific). RNA quality and quantity was determined using a Bioanalyzer 2100 (Agilent Technologies). RNA samples were reverse transcribed, amplified, labeled, and fragmented using Ovation Pico WTA, WT Ovation Exon Module, and Encore Biotin Module (NuGen) and hybridized with a whole-transcript gene array on a Mouse Gene 1.0 ST array chip by the Ramaciotti Centre for Genomics (University of New South Wales). One of four LZhi samples did not pass the quality control data assessment of the microarray (Console) and was therefore excluded from the analysis. Computational analysis of gene expression was performed on GenePattern (data normalization, determination of differential gene expression by LimmaGP, and GSEA preranked by fold-change; Broad Institute). For generation of heat maps, transcripts were excluded if they failed to reach a minimal mean expression of log2(x) ≥4. Cutoffs (fold-change and p-values) are indicated in the relevant figures. Genes displayed in heat maps were hierarchically clustered using Pearson correlation.

Immunofluorescence histology {#s09}
----------------------------

Splenic cryosections were prepared and stained as previously described ([@bib9]) using the antibodies and fluorescent reagents. Slides were imaged on an upright microscope (DM5500; Leica Biosystems), and images were analyzed using Photoshop CS5 (version 12.1; Adobe). Strong staining was observed for PC-lineage cells expressing high levels of cytoplasmic IgG1 in addition to weak cell surface staining for IgG1^+^ GC B cells. For clarity, images of IgG1^+^ cells presented in this study show only the brightly staining PC-lineage cells.

Statistical analysis {#s10}
--------------------

Statistical analyses were undertaken using a paired or unpaired two-tailed Student's *t* test in Prism (GraphPad Software). Significant p-values are indicated in figures for the following ranges: \*, 0.01 ≤ P \< 0.05; \*\*, 0.001 ≤ P \< 0.01; \*\*\*, P \< 0.001. In all summary figures, each data point represents an individual mouse, and bars represent the mean. In bar graphs, error bars represent standard error of the mean.

Accession no. {#s11}
-------------

Gene expression microarray data were deposited to the Gene Expression Omnibus under accession no. [GSE94638](GSE94638).

Online supplemental material {#s12}
----------------------------

Fig. S1 shows the SHM analysis in the four GC compartments on day 9 of the response of SW~HEL~ B cells to HEL^3X^-SRBCs. Fig. S2 shows GSEA analyses of LZ and DZ gene expression signatures and flow cytometric detection of *Blimp1*-GFP^+^ PC-lineage cells in the four GC compartments. Fig. S3 shows the effects of antibody treatments on GC size and composition as well as additional immunofluorescence histology analysis of IgG1^+^ PC-lineage cells within GC structures.
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